Although most studies verified that SPARCL1 was a potential tumor suppressor gene across cancer types [22, 24, 25], the results were not completely consistent, indicating different biological mechanisms of SPARCL1 in different cancers. This evidence concerns the gene SPARCL1 and cancer.